Interacting Drugs |
Nadolol vs Calcium Channel Blockers (Dihydropyridine) |
Security Level |
 |
Mechanism |
Calcium Channel Blockers (Dihydropyridine): May enhance the hypotensive effect of Beta-Blockers. Bradycardia and signs of heart failure have also been reported. |
Management |
Monitor therapy |
Nadolol vs Calcium Channel Blockers (Dihydropyridine)
Post Review about Nadolol vs Calcium Channel Blockers (Dihydropyridine) Click here to cancel reply.
Other Interactions of Nadolol
Other Interactions of Calcium Channel Blockers (Dihydropyridine)
Latest News
- FDA approves Ruconest for treatment of hereditary angioedema
- FDA recommend against aspirin to prevent First Heart Attacks
- FDA approves Pomalyst (pomalidomide) for advanced multiple myeloma
- FDA approves three new drug treatments for type 2 diabetes
- Long-term consequences of vaginal delivery on the pelvic floor
No comments yet.